Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

October 13, 2016

Study Completion Date

October 13, 2016

Conditions
Postpartum Depression
Interventions
DRUG

Leuprolide Acetate

All subjects will receive one IM injection (3.75 mg) each month for four months.

DRUG

Micronized estradiol

All participants will receive micronized estradiol daily for eight weeks. Estradiol will be started at a dose of 4 mg/day and increased progressively up to 10 mg/day.

DRUG

Progesterone

All subjects will receive micronized progesterone daily for eight weeks. Progesterone will be started at 400 mg/day and increased progressively up to 800 mg/day.

Trial Locations (1)

27599-7175

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

Foundation of Hope, North Carolina

OTHER

collaborator

North Carolina Translational and Clinical Sciences Institute

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT01762943 - Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition | Biotech Hunter | Biotech Hunter